Rats In DM Group Research Articles

Exercise promotes irisin expression to ameliorate renal injury in type 2 diabetic rats

To investigate the role of irisin in exercise-induced improvement of renal function in type 2 diabetic rats. Forty male SD rats aged 4-6 weeks were randomized into normal control group, type 2 diabetes mellitus model group, diabetic exercise (DE) group and diabetic irisin (DI) group (n=8). The rats in DE group were trained with treadmill running for 8 weeks, and those in DI group were given scheduled irisin injections for 8 weeks. After the treatments, blood biochemical parameters of the rats were examined, and renal histopathology was observed with HE, Masson and PAS staining. Western blotting was used to detect the protein expression levels in the rats'kidneys. The diabetic rats showed significantly increased levels of fasting insulin, total cholesterol, triglyceride, serum creatinine and blood urea nitrogen with lowered serum irisin level (all P < 0.05). Compared with those in DM group, total cholesterol, triglyceride, serum creatinine and blood urea nitrogen levels were decreased and serum irisin levels were increased in both DE and DI groups (all P < 0.05). The rats in DM group showed obvious structural disorders and collagen fiber deposition in the kidneys, which were significantly improved in DE group and DI group. Both regular exercises and irisin injections significantly ameliorated the reduction of FNDC5, LC3-II/I, Atg7, Beclin-1, p-AMPK, AMPK and SIRT1 protein expressions and lowered of p62 protein expression in the kidneys of the diabetic rats (all P < 0.05). Both exercise and exogenous irisin treatment improve nephropathy in type 2 diabetic rats possibly due to irisin-mediated activation of the AMPK/SIRT1 pathway in the kidneys to promote renal autophagy.

Sodium-glucose cotransporter-2 inhibitor alleviated atrial remodeling in STZ-induced diabetic rats by targeting TLR4 pathway.

PurposeThe mechanism of sodium–glucose cotransporter-2 inhibitor (SGLT-2i) reducing the incidence of atrial fibrillation remains unclear. We hypothesize that sodium–glucose cotransporter-2 inhibitor alleviated atrial remodeling in STZ-induced diabetic rats by targeting TLR4 pathway.MethodsA total of 42 rats were randomly assigned into three groups: control group (CON group); diabetes group (DM group): diabetes mellitus rats were established by 65 mg/kg streptozotocin (STZ) intraperitoneal injection; and diabetes + dapagliflozin group (DM + DAPA group): diabetic rats were given DAPA gavage administration (DAPA 2mg/kg/d for 4 weeks by gavage administration), 14 rats in each group. Epicardial multiple-lead recording and intracardiac electrophysiology studies were performed to investigate the electrical remodeling in the heart and the atrial fibrillation inducibility in each group. Western blot analysis and real-time PCR were used to determine the protein and mRNA expression of toll-like receptor 4 (TLR4), interleukin receptor-associated kinase 1 (IRAK1), tumor necrosis factor receptor-associated factor 6 (TRAF6), nuclear factor-kappa B (NF-κB), and type I collagen (collagen I).ResultsCompared with rats in CON group, rats in DM group showed marked myocardial fibrosis, ectopic pacing excitement, reduced conduction velocity, decreased cardiac function. TLR4/IRAK1/TRAF6/NF-κB, collagen I proteins expressions and incidence of atrial fibrillation (27.3%) were increased in DM group. Parts of these changes were reversed by treatment of DAPA. Incidence of atrial fibrillation was decreased in DM + DAPA group (2.8%).ConclusionsSGLT-2i dapagliflozin may prevent diabetic rats' atrial remodeling and reduce the inducibility of atrial fibrillation partly by targeting TLR4/IRAK1/TRAF6/NF-κB inflammatory pathway.

Mots-c Attenuates Myocardial Mitochondrial Damage Through Inhibition Of Ccn1/erk1/2/egr1 Pathway

Mitochondrial dysfunction is considered as a major contributor to cardiac systolic and diastolic dysfunction in diabetes. As a newly identified mitochondria derived peptide, MOTS-c plays a vital role in the regulation of metabolic homeostasis and was shown to be closely related to type 2 diabetes (T2D). We hypothesized that MOTS-c could prevent myocardial mitochondrial damage and improve cardiac structure and function in T2D. PURPOSE: To explored the effects and molecular mechanisms of MOTS-c on mitochondrial damage and cardiac dysfunction in diabetes. METHODS: Thirty male Sprague Dawley rats were randomly divided into three groups: control (C, n = 10), diabetes (D, n = 10) and diabetes plus MOTS-c treatment (DM, n = 10). Diabetic rats induced by high-fat high-sugar diet combined with a low-dose streptozotocin (30 mg/kg) injection. Rats in DM group were injected with MOTS-c at a dose of 0.5 mg/kg/day and 7 days/week for 8 weeks. Echocardiography was used to measured cardiac systolic and diastolic function, and transmission electron microscopy (TEM) was used to observed myocardial ultrastructure. RNA sequencing was used to determin differentially expressed genes (DEGs). Gene Ontology (GO) were selected for functional enrichment analysis to screen out the related pathways and genes, and qRT-PCR was used to measure the mRNA expression levels of CCN1, ERK1/2 and EGR1. RESULTS: MOTS-c treatment significantly prevented mitochondrial swelling and vacuoles and repaired the disorder of myocardial fiber arrangement. There was no significant differences in ejection fraction (EF), E-wave peak, A-wave peak and E/A ratio between DM and C groups (all p > 0.05). 8-week MOTS-c treatment altered 47 causative genes in myocardium of diabetic rats. The results of GO enrichment analysis showed that CCN1 and EGR1 were highly expressed and appeared in the apoptosis related terms. CCN1 was included in the ERK1/2 cascade with the highest significance. The mRNA expression of CCN1, ERK2 and EGR1 were significantly decreased after MOTS-c treatment (p < 0.01). CONCLUSIONS: MOTS-c improves myocardial mitochondrial damage and attenuates the cardiac pathological remodeling and dysfunction. CCN1/ERK1/2/EGR1 pathway may play an important role in MOTS-c preventing myocardial damage in diabetes.

Expression and Mechanism of TXNIP/NLRP3 Inflammasome in Sciatic Nerve of Type 2 Diabetic Rats.

Objective To determine the expression profiling and mechanism of thioredoxin-interacting protein (TXNIP)/nucleotide-binding domain-like receptor protein 3 (NLRP3) inflammasome pathway in sciatic nerve (SN) of type 2 diabetes mellitus (T2DM) rats. Methods Ten out of the 35 healthy SD rats (specific pathogen free) purchased were randomized into the control group, while the others were established a T2DM model by feeding a high-fat and high-sugar diet plus laparoscopic injection of 1% streptozotocin (STZ). The successfully modeled rats were subgrouped into two arms: a DM group with 10 rats and a resveratrol- (RES-) treated DM intervention group with 11 rats. Normal saline to control and DM groups. Alterations in fasting blood glucose (FBG) and body weight (BW) at different time points after administration were observed. Sciatic nerve conduction velocity (SNCV) and mechanical pain threshold (MPT) were measured. TXNIP, NLRP3, caspase-1, and interleukin- (IL-) 1β levels in rat SN tissue were determined. Results DM group rats showed higher FBG and lower BW than control rats at different time points (P < 0.05). The FBG of DM intervention group at 2, 4, and 6 weeks after administration was lower, and the BW at 4 and 6 weeks after dosing was higher than DM group. Higher MPT and SNCV were determined in DM intervention group versus DM group (P < 0.05). DM group rats had disordered, swollen, and dissolved SN myelin sheath structure; TXNIP inhibition led to a small amount of nerve myelin fragments and mild pathological changes. Lower TXNIP, NLRP3, caspase-1, and IL-1β protein levels were found in DM intervention group versus DM group (P < 0.05). Conclusion The pathogenesis of peripheral neuropathy in T2DM rats may be linked to TXNIP/NLRP3 inflammasome pathway activation, indicating the potential of this pathway as a therapeutic target for diabetic peripheral neuropathy (DPN).

POS-352 MiR-26a-5p PROTECTS PODOCYTE FROM APOPTOSIS VIA DOWNREGULATION OF TRPC6 IN TYPE 2 DIABETIC NEPHROPATHY

Podocyte injury is a major etiological factor in diabetic nephropathy (DN), while transient receptor potential cationic channel 6 protein (TRPC6) channels play a key role in podocyte injury. Our study is designed to investigate the regulatory effect of microRNA-26a-5p (miR-26a-5p) on DN podocyte injury induced by TRPC6 and the underlying mechanisms. 20 SPF, 8-week male Sprague-Dawley (SD) rats were used for establishing the type 2 diabetic mellitus (T2DM) group by feeding them with high fat and high sugar food for 8 weeks and intraperitoneal injection of low-dose streptozotocin (STZ, 30mg/kg). Another 10 normal male SD rats were selected as normal control group (NC). The 24h urinary albumin excretion rate (UAE), urinary creatinine (Ucr), creatinine clearance rate (CCr) and other major biochemical parameters including the fasting insulin level (FINS), serum creatinine (Scr), fasting blood glucose (FBG), total cholesterol (TC), triglyceride (TG), high density lipoprotein (HDL), low density lipoprotein (LDL) were measured in both groups after establishing the DM models. Light and electron microscope were used to observe the pathology of kidneys and podocyte ultrastructures, respectively. Immunohistochemical method was used to show the distribution of nephrin and TRPC6 protein. To determine the expression of nephrin, TRPC6, apoptotic-associated proteins (cleaved-caspase-3 and bax/bcl-2), western blot was applied. qRT-PCR was used to detect miR-26a-5p and mRNAs of nephrin, TRPC6, cleaved-caspase-3 and bax/bcl-2. Podocyte apoptotic rate was measured using TUNEL method. Cultured immortalized mouse podocytes (MPC5) were divided into three groups: normal glucose group (NG), hypertonic group (HM), high glucose group (HG). Before and after miR-26a-5p mimics and inhibitor transfecting, the expression and mRNAs of nephrin, TRPC6, cleaved-caspase-3 and bax/bcl-2 were detected again using the same methods. Flow cytometry (FCM) was uesd to detect podocyte apoptosis. 1. Compared with NC group, rats in DM group exhibited disrupted biochemical conditions, for uAER, CCr, FINS, FBG, TC, TG and LDL were all significantly increased (all P <0.05) while HDL were decreased (P <0.05), along with significant insulin resistance. 2. Increased glomeruli volume, mesangial cell proliferation, thickened basement membrane and foot process fusion could be observed by light and electron microscope. 3. Immunochemistry results showed a increased expression of TRPC6 and a decreased of nephrin in DM rats than those in NC group (both P <0.05). 4. Both qRT-PCR and Western blot results in vivo and in vitro showed a notable increase in the expression of TRPC6, cleaved-caspase-3 and bax/bcl-2 and decrease in the expression of nephrin and miR-26a-5p (P <0.05). TUNEL and flow cytometry indicated higher podocyte apoptosis in DM rats and HG group. 5. The expression of TRPC6, cleaved-caspase-3 and bax/bcl-2 were down-regulated and nephrin expression was restored after miR-26a-5p mimics transfection (all P <0.05), while miR-26a-5p inhibitor intervention could aggravate all above changes as the effects of HG on podocytes (all P <0.05). High-glucose condition significantly decreased miR-26a-5p expression and increased TRPC6 expression and podocyte apoptosis. In DN, miR-26a-5p can protect podocyte from apoptosis via down-regulating the expression of TRPC6.

Tip 2 Diyabetik Sıçanlarda Kurkuminin Streptozosin Kaynaklı Pankreatik Adacık Hasarına Karşı Koruyucu Etkisi: Deneysel Bir Çalışma

Objective: The aim of study of was to determine the damage caused by streptozocin (STZ)-induced Type 2 diabetes in pancreatic islet in rats and the effect of curcumin on this damage. Material and Methods: A total of 32 (250-320 g) Wistar albino male rats were used. Rats were randomly divided into 4 groups as Control (C), Diabetes (DM), Curcumin (CUR), and Diabetes+Curcumin (DM+CUR) (n=8). Histopathological, stereological and immunohistochemical analyzes were used to determine the damage caused by type 2 diabetes in the pancreatic tissue and the effect of curcumin on this damage. Results: In the histopathological evaluation of pancreatic tissues, in pancreatic sections of DM group rats, the islets were smaller and their borders were irregular, and degenerative and necrotic changes were observed in the cells. In the DM+CUR group, it was determined that these degenerative changes in the islets of Langerhans and cells were alleviated. In the stereological analysis, it was determined that the islet volume, the ratio of islets to the pancreas and the number of beta cells in the DM group were statistically significantly decreased compared to the other groups, and it was found to be higher in the DM+CUR group than in the DM group (p<0.05). In the immunohistochemical evaluation, the C and CUR groups showed similar staining with Ki67, whereas the staining was less in the diabetic group. In the diabetes group treated with curcumin, it was found that curcumin attenuated the diabetes- related Ki67 reduction. Conclusion: In this study, it was determined that curcumin reduced the damage in the islets and beta cells in the pancreas of rats with diabetes mellitus with STZ and provided a significant protection in the pancreatic tissue.

Wound healing mechanisms in rats with streptozotocin-induced diabetes mellitus

Background. Wound healing disorders and formation of diabetic foot, a severe disabling complication of diabetes mellitus, are accompanied by nervous system impairment and/or ischemia.&#x0D; Objective — the study was aimed at assessing the effect of peripheral innervation disorders on the regulation of tissue repair in the streptozotocin-induced rat model of diabetes mellitus.&#x0D; Material and methods. The study was carried out in male white outbred rats (n=70). The animals were wounded 42 days after induction of diabetes by injecting streptozotocin (diabetes group; this group received insulin Levemir at a dose of 2 units/kg in saline subcutaneously to reduce mortality), or after injection of citrate buffer (CB group). Skin samples were taken on day 8, 16, and 24 after wound modeling. Pain sensitivity was assessed in all animals. The resulting skin fragments were fixed, dehydrated, and embedded in paraffin according to standard procedures. Sections were stained with hematoxylin and eosin, antibodies specific for Ki-67, α1, β1, and β2-adrenoreceptors were used for immunohistochemical staining. Intact animals were used as an additional control group.&#x0D; Results. Tail withdrawal time measured on day 56 was higher in DM group rats as compared to the control group (p=0.017). CB group demonstrated a tendency towards more rapid wounds healing than diabetic animals, although the difference was not statistically significant due to wide scatter of data in the DM group (p=0.64). The intensity of staining for Ki67 was lower in the DM group (p=0.045). Reduced density of β2-adrenoreceptors was observed at the areas remote from the wound in CB group rats.&#x0D; Conclusion The results show no correlation between altered innervation and impaired tissue repair in rats with streptozotocin-induced diabetes.

Probucol improves erectile function via Activation of Nrf2 and coordinates the HO-1 / DDAH / PPAR-γ/ eNOS pathways in streptozotocin-induced diabetic rats

BackgroundDiabetic erectile dysfunction (DMED) is mainly attributed to oxidative stress, and Nrf2 plays an important role in cellular antioxidation and regulates NO production in the vascular endothelium. Probucol maintains endothelial function through its antioxidant activity. This study investigated the efficacy and mechanism of probucol in improving erectile function in streptozotocin-induced diabetic rats. MethodsIn our study, thirty 12-week-old Sprague-Dawley male rats were fasted for 12 h. All rats received a 1-time injection of intraperitoneal streptozotocin(60 mg/kg) or vehicle. After 72 h, STZ-treated rats (with random blood glucose concentrations consistently greater than 16.7 mmol/L) were considered diabetic. The diabetic rats were randomly assigned into 2 groups and treated with daily gavage feedings of probucol at doses of 0 and 500 mg/kg for 12 weeks. A positive control group underwent intraperitoneal injection of normal saline followed by daily gavage of saline solution. Erectile function was assessed by electrical stimulation of the cavernous nerves with real-time intracavernous pressure measurement. After euthanasia, penile tissue was investigated using immunohistochemistry, Western blot, and ELISA to assess the proteins of Nrf2/HO-1/DDAH/PPAR-γ/eNOS pathways. ResultsAfter treatment, the rats in the probucol group presented significantly improved erectile function (P < 0.05) than that of the diabetic group without probucol treatment (DM). Also, protein expression of Nrf2, DDAH, PPAR-γ, HO-1 and eNOS was significantly higher than that of the DM group (P < 0.05). CGMP concentrations and SOD concentrations of probucol-treated rats were higher than those of DM group (P < 0.05). The MDA levels and ADMA levels were significantly lower than those of DM group rats (P < 0.05). ConclusionProbucol can improve erectile function via activation of Nrf2, which coordinates the HO-1/DDAH/PPAR-γ/eNOS pathways in streptozotocin-induced diabetic rats.

Plasma Pharmacokinetic Determination of Canagliflozin and Its Metabolites in a Type 2 Diabetic Rat Model by UPLC-MS/MS.

Canagliflozin is a novel, orally selective inhibitor of sodium-dependent glucose co-transporter-2 (SGLT2) for the treatment of patients with type 2 diabetes mellitus. In this study, a sensitive and efficient UPLC-MS/MS method for the quantification of canagliflozin and its metabolites in rat plasma was established and applied to pharmacokinetics in a type 2 diabetic rat model. We firstly investigated the pharmacokinetic changes of canagliflozin and its metabolites in type 2 diabetic rats in order to use canagliflozin more safely, reasonably and effectively. We identified three types of O-glucuronide metabolites (M5, M7 and M17), two kinds of oxidation metabolites (M8 and M9) and one oxidation and glucuronide metabolite (M16) using API 5600 triple-TOF-MS/MS. Following liquid–liquid extraction by tert-butyl methyl ether, chromatographic separation of canagliflozin and its metabolites were performed on a Waters XBridge BEH C18 column (100 × 2.1 mm, 2.5 μm) using 0.1% acetonitrile–formic acid (75:15, v/v) as the mobile phase at a flow rate of 0.7 mL/min. Selected ion monitoring transitions of m/z 462.00→191.10, 451.20→153.10, 638.10→191.10 and 478.00→267.00 were chosen to quantify canagliflozin, empagliflozin (IS), O-glucuronide metabolites (M5, M7 and M17), and oxidation metabolites (M9) using an API 5500-triple-MS/MS in the positive electrospray ionization mode. The validation of the method was found to be of sufficient specificity, accuracy and precision. The pathological condition of diabetes could result in altered pharmacokinetic behaviors of canagliflozin and its metabolites. The pharmacokinetic parameters (AUC0–t, AUC0–∞, CLz/F, and Vz/F) of canagliflozin were significantly different between the CTRL and DM group rats (p < 0.05 or p < 0.01), which may subsequently cause different therapeutic effects.

Analysis of serum undercarboxylated osteocalcin level in rats with type 2 diabetes mellitus and the correlation with cognitive impairment.

The aim of the study was to investigate the correlation between the serum undercarboxylated osteocalcin (ucOC) level and the blood biochemistry and cognitive impairment in rats with type 2 diabetes mellitus (T2DM). Sprague-Dawley (SD) rats were randomly divided into the normal control group (NC) and type 2 DM group. DM group received the high-fat and high-sugar diet combined with the intraperitoneal injection of low-dose STZ to establish the type 2 DM rat model. After 12 weeks of feeding, a Morris water maze was used to observe the rats' cognitive ability, and the levels of blood lipid, ucOC, insulin and adiponectin in the two groups were measured. The results showed that blood glucose of rats in DM group was increased significantly at 2–12 weeks (p<0.01) and the body weight was significantly increased at 4–12 weeks (p<0.01). The levels of serum triglyceride (TG), total cholesterol, low-density lipoprotein and insulin in rats in DM group were significantly increased compared with those in NC group (p<0.01) and the levels of high-density lipoprotein, adiponectin and ucOC were significantly decreased compared with those in the NC group (p<0.01). The place navigation and spatial exploration capacities of rats in DM group were significantly decreased compared with those in NC group (p<0.01). In the DM group, the place navigation and spatial exploration capacities of rats in the low ucOC group were significantly decreased compared with those in the high ucOC group (p<0.01). Additionally, single-factor correlation analysis revealed that ucOC was negatively correlated with blood glucose, TG and escape latency (p<0.01), but was positively correlated with adiponectin, residence time in target quadrant and traversing times (p<0.05 or p<0.01). In conclusion, the decreased serum ucOC level in rats with type 2 diabetes mellitus has a certain correlation with cognitive impairment.

Effects of aerobic exercise combined with melatonin on osteoporosis of type II diabetic rats

To investigate the effects of aerobic exercise and melatonin on osteoporosis in type 2 diabetic rats. Sixty fe male SD rats were randomly divided into the control group (n=10) and the diabetic model group (n=50). The rats in the control group(N group) did not receive any intervention, and the rats in the type Ⅱ diabetic group (D) was injected with streptozocin(STZ) at the dose of 35 mg/kg by intraperitoneally. One week later, rats with blood glucose greater than 16.7 mmol/L were successfully modeled for type Ⅱ diabetes. Forty diabetic rats were randomly divided into diabetic control group (D), diabetes + aerobic exercise group(CDE),diabetes + melatonin group (DM), diabetes mellitus + aerobic exercise + melatonin group (DEM), 10 rats in each group. The rats in DE and DEM groups were treated with 20 min aerobic exercise for 6 weeks. The rats in DM group and DEM group were given 40 mg/kg of melatonin per day. The body weight, vertebrae and left and right femur bone mineral density (BMD) of the rats in each group were observed. Malondialdehyde(MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), serum total calcium (Ca), inorganic phosphate (P) and parathyroid hormone (PTH) were detected. Compared with N group, body weight, serum SOD, GSH-Px levels, blood Ca, lumbar and femoral BMD of rats in group D were decreased significantly (P < 0.05 or P < 0.01). The levels of blood glucose, serum MDA and serum PTH were increased sig-nificantly (P < 0.01), the level of blood P had no changes (P > 0.05); compared with group D, DE group, DM group rats body weight, serum SOD, GSH-Px levels, blood Ca, lumbar spine and femur about BMD were increased significantly (P < 0.05 or P < 0.01). The levels of blood glucose, serum MDA and serum PTH were decreased significantly (P < 0.05 or P < 0.01), the level of blood P had no changes (P > 0.05). The effects in diabetic rats treated with aerobic exercise and melatonin at the same time were much better. Both aero-bic exercise and melatonin can improve diabetic osteoporosis, and the effect of both joint intervention is more significant, it may be associated with oxidative stress by increasing the ability of diabetic rats, regulate glucose metabolism in order to effectively reduce the calcium and PTH, improve BMD to alleviate osteoporosis.

Protective effects of Curcumin analogue L6H4 on kidney from type 2 diabetic rats

To investigate the protective effect of curcumin analogue L6H4 on the kidney from the type 2 diabetic rats. Twenty-four SPF male SD rats were randomly divided into 3 groups(n=8):normal control group(NC),diabetes mellitus group(DM) and DM+L6H4-treatment group(DT). After rats were fed with high-fat diet for 4 weeks, both the DM and DT groups were injected with streptozotocin intraperitoneally to induce type 2 diabetes mellitus models. The rats in DT group were given L6H4 by gavage at the dose of 0.2 mg/kg·d for 8 weeks. After the treatment, the 24 h urinary protein, fasting blood glucose (FBG), triglyceride (TG), serum creatinine(Scr),blood urea nitrogen (BUN) and uric acid (UA) were detected biochemically. The pathological changes of the kidneys were observed under light and transmission electron microscopes. The expressions of TGF-β1, FN and Col IV were detected by immunohistochemistry. The levels of the 24 h urinary protein, FBG, TG, Scr and BUN were elevated significantly in diabetic group(P<0.01). The glomerular volume of DM group rats became irregularly enlarged, diffused mesangial matrix accumulated, with basal membrane proliferous hypertrophy and fusion phenomenon of foot process, the expressions of TGF-β1,FN and Col-IV were elevated significantly (P<0.05). After treated with L6H4, the levels of the 24 h urinary protein, FBG, TG, Scr and BUN were decreased in DT group compared to DM group (P<0.01), the morphological changes of kidney were ameliorated. The expression levels of TGF-β1, FN and Col-IV were downregulated (P<0.05). L6H4 exerts the protective effect on kidneys of type 2 diabetic rats by reducing expression of TGF-β1, inhibiting secretion of Col-IV and FN, relieving the deposition of the extracellular matrix.

Icariside II ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats.

PurposeTo investigate the therapeutic effects and potential mechanisms of icariside II (ICA II) on reversing diabetic nephropathy in streptozotocin (STZ)-induced type I diabetic rats.MethodsNewborn male Sprague Dawley rats were labeled with thymidine analog 5-ethynyl-2-deoxyuridine (EdU) for tracking endogenous label retaining progenitor cells (LRCs). At age of 8 weeks, 48 rats were randomly divided into three groups: normal control group (n=16), diabetes mellitus group (DM; n=16), and diabetes mellitus plus ICA II therapy group (DM+ICA II, n=16). Eight weeks induced for diabetes with STZ, rats in DM group and DM+ICA II group were treated with vehicle or ICA II (5 mg/kg/day) for another 8 weeks, respectively. Then, blood creatinine, 24-hour urine protein, blood urea nitrogen, and glycosylated hemoglobin were measured, as well as the expression of von Willebrand factor, malondialdehyde, transforming growth factor-β/drosophila mothers against decapentaplegic protein/connective tissue growth factor (TGF-β/Smad/CTGF) signaling, marker of proliferation Ki-67, and EdU+ LRCs in renal tissues.ResultsIncreased levels of creatinine, 24-hour urine protein, and blood urea nitrogen and remarkably decreased proportion of normal glomeruli and increased proportions of I, IIa, IIb, and III glomeruli were observed in diabetic rats, while ICA II could reverse these changes. Interestingly, ICA II could significantly downregulate the levels of malondialdehyde and TGF-β/Smad/CTGF signaling and increase the expression of von Willebrand factor, Ki-67, and EdU+ LRCs in the kidney.ConclusionICA II treatment could ameliorate diabetic nephropathy in STZ-induced diabetic rats by increasing endothelial cell contents, downregulating TGF-β/Smad/CTGF signaling pathway and oxidative stress level, and promoting cell proliferation both in kidney cortex and medulla. These beneficial effects appear to be mediated by its antioxidant capacity and recruitment of endogenous EdU+ progenitor cells into the kidney tissue.

Effect of Trace Element Strontium on Serum Indexes in the Blood of Rats with Type I Diabetic

This paper is to investigate the influence of trace element strontium on the content of blood glucose, glycated hemoglobin, triglycerides, non-esterified fatty acid and total cholesterol in type I diabetes rats blood. Methods: Adult Wistar rats weighing 220~250g, half male and half female were used in the experiment. One-time intraperitoneal injection of Streptozotocin (STZ) 60mg/kg was administrated to rats. Three days later, the rats that have fasting blood glucose more than 16.7 mmol/L were the diabetes model rats (DM rats). Then DM rats were randomly divided into group A, rats drinking mineral water with Sr 2mg/L; group B,rats drinking mineral water with Sr 4mg/L; group C, rats drinking mineral water with Sr 6mg/L; group D, rats drinking mineral water with Sr 8mg/L and DM group rats drinking tap water, 32 rats in each group (N = 32). 8 rats in each group after the first month, the second month, the third month, and the fourth month were randomly killed and the blood was collected. Then the blood was used for evaluation of blood glucose, glycosylated hemoglobin, triglycerides, non-esterified fatty acid and total cholesterol.

Experimental study of leflunomide on renal protective effect and on inflammatory response of streptozotocin induced diabetic rats

To further reveal the effects of leflunomide on renal protection and on inflammatory response using streptozotocin (STZ) induced diabetic rats. Male Wistar rats were randomly divided into normal control group (NC), diabetic group (DM) and leflunomide treatment group (LEF). LEF group rats were given leflunomide (5 mg/kg) once daily. At the end of the 12th week, general biochemical parameters in three groups were determined. The renal histopathology was observed by light microscopy and electron microscopy. Further biochemical analysis of the gene and protein expression of nuclear factor kappa B (NF-κB), tumour necrosis factor-alpha (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and ED-1 positive cells in renal tissue were provided using real-time reverse transcription-polymerase chain reaction and immunohistochemistry. Compared with NC group rats, systolic blood pressure, blood glucose (BG), glycohemoglobin (HbAlc), renal hypertrophy index, urine albumin excretion rate (AER) and serum creatinine were increased in DM group rats (P < 0.05). Treatment with leflunomide can improve these parameters except systolic blood pressure, BG and HbAlc. Creatinine clearance rate (Ccr) in the DM group was significantly lower than that of the NC group, and leflunomide can increase its level. Compared with DM group rats, the pathological damages were significantly relieved in LEF group rats. Compared with NC group rats, the gene and protein expressions of NF-κB, TNF-α, MCP-1 and ED-1 positive cells in renal tissue of DM group rats were highly upregulated (P < 0.01). Leflunomide suppressed their high expressions in renal tissue of diabetic rats. Leflunomide can ameliorate the kidney structure and function injury of diabetic rats through suppressing the expression of NF-κB, TNF-α, MCP-1 and macrophage infiltration in renal tissue.

Toxic effect of TiO&lt;SUB&gt;2&lt;/SUB&gt; nanoparticles against human lung cancer cell line A549

Objective To investigate the protective effect of compound Xueshuantong capsule against damage of diabetic nephropathy in rat diabetic model.Methods Male SD rats were given intraperitoneal injection of streptozotocin(STZ)at 60mg/kg, and diabetic rat model was deemed successfully induced when the blood glucose level≥16.7mmol/L 3days after injection.Thirty model rats were randomly divided into the following 3groups equally:diabetic model group(DM),compound Xueshuantongcapsule group(XST),andα-lipoic acid treatment group(ALA).Another 10normal rats served as normal control group(NG).The body weight,blood glucose,blood fat,kidney weight/body weight(KW/BW),24h-urinary protein excretion,urea nitrogen,and serum creatinine were observed and compared between different groups after 12weeks’treatment.The ultrastructure changes of kidney were observed by electron microscopy and light microscope.Results Compared with NG group,rats in DM group had a higher 24h-urinary protein excretion(P0.05),and those in XST group and ALA group had a significantly lower one compared with the DM group(P0.05).Compared with NG group,rats in the other 3groups had a higher KW/BW,with significant difference found between DM group and XST group(P0.05).Electron microscopic results showed uneven glomerular basement membrane thickening, foot process integration,and mesangial cell proliferation in the model group;all the above changes were improved in the XST and ALA groups.Conclusion Compound Xueshuantongcapsule can lower the 24h-urinary protein secretion,decrease KW/BW,and improve the structure of glomerular basement membrane,thus exerting renal protective effect in diabetic rats.

1P-0023 Amount of thrombus at culprit lesion of acute myocardial infarction is dependent on angioscopically determined coronary atherosclerosis

Diabetic erectile dysfunction (DMED) is mainly attributed to oxidative stress, and Nrf2 plays an important role in cellular antioxidation and regulates NO production in the vascular endothelium. Probucol maintains endothelial function through its antioxidant activity. This study investigated the efficacy and mechanism of probucol in improving erectile function in streptozotocin-induced diabetic rats.In our study, thirty 12-week-old Sprague-Dawley male rats were fasted for 12 h. All rats received a 1-time injection of intraperitoneal streptozotocin(60 mg/kg) or vehicle. After 72 h, STZ-treated rats (with random blood glucose concentrations consistently greater than 16.7 mmol/L) were considered diabetic. The diabetic rats were randomly assigned into 2 groups and treated with daily gavage feedings of probucol at doses of 0 and 500 mg/kg for 12 weeks. A positive control group underwent intraperitoneal injection of normal saline followed by daily gavage of saline solution. Erectile function was assessed by electrical stimulation of the cavernous nerves with real-time intracavernous pressure measurement. After euthanasia, penile tissue was investigated using immunohistochemistry, Western blot, and ELISA to assess the proteins of Nrf2/HO-1/DDAH/PPAR-γ/eNOS pathways.After treatment, the rats in the probucol group presented significantly improved erectile function (P < 0.05) than that of the diabetic group without probucol treatment (DM). Also, protein expression of Nrf2, DDAH, PPAR-γ, HO-1 and eNOS was significantly higher than that of the DM group (P < 0.05). CGMP concentrations and SOD concentrations of probucol-treated rats were higher than those of DM group (P < 0.05). The MDA levels and ADMA levels were significantly lower than those of DM group rats (P < 0.05).Probucol can improve erectile function via activation of Nrf2, which coordinates the HO-1/DDAH/PPAR-γ/eNOS pathways in streptozotocin-induced diabetic rats.